Energenesis Biomedical CO.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 3.592 million compared to TWD 2.839 million a year ago. Operating loss was TWD 54.750 million compared to TWD 67.898 million a year ago. Net loss was TWD 53.897 million compared to TWD 66.083 million a year ago. Basic loss per share was TWD 0.9 compared to TWD 1.12 a year ago.